Taiji Group calls for overhaul of litigation process

Based in Chongqing, the Taiji Group Co Ltd, one of the leading pharmaceutical companies in China, has always attached great importance to supporting the protection of intellectual property rights and it has been put this principle into practice for decades. Its impressive and rapid development relies heavily on the practice of patent protection.

Owning three listed companies, including the Taiji group, Southwest Pharmaceutical and Tongjunge, the company has invested heavily in maintaining its leading edge in patent protection. Its intangible assets, including 96 granted patents and more than 400 trademarks, have contributed hugely to its success.

At present, all of its top 10 best-performing products enjoy intellectual property protection. For example, its new product, "Donatello" (rosiglitazone sodium), is the first compound patent product in the field of diabetes with independent intellectual property rights made in China.